Tibor Kovacsovics, MD
Hematology & Oncology · Portland, ORNPI 1396750899
Payments from drug & device makers
Across 472 payments — averaging $5652.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$886K
- AstraZeneca$566K
- Novartis$525K
- Janssen Research & Development, LLC$188K
- Pfizer$169K
- Amgen$123K
- plus $211K from 23 others
Across 11 payments — averaging $1077.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$7K
- Novartis$4K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 125 | $886,324 |
| AstraZeneca(2 entities) | 12 | $565,903 |
| Novartis | 15 | $525,070 |
| Janssen Research & Development, LLC | 53 | $188,292 |
| Pfizer | 41 | $168,672 |
| Amgen | 29 | $122,736 |
| Gilead(2 entities) | 10 | $70,066 |
| Rigel Pharmaceuticals, Inc. | 26 | $29,614 |
| Boehringer Ingelheim International GmbH | 4 | $25,226 |
| Jazz Pharmaceuticals Inc. | 30 | $20,232 |
| Stemline Therapeutics Inc. | 18 | $11,855 |
| Astellas Pharma Global Development | 10 | $9,235 |
| Servier Pharmaceuticals LLC | 16 | $9,172 |
| Beone Medicines USA, Inc. | 2 | $7,534 |
| Genentech, Inc. | 4 | $7,364 |
| Agios Pharmaceuticals, Inc. | 10 | $6,007 |
| Bio Products Laboratory USA, Inc. | 8 | $4,958 |
| Astellas Pharma US Inc | 2 | $3,567 |
| Syndax Pharmaceuticals, Inc. | 7 | $2,673 |
| Daiichi Sankyo Inc. | 31 | $2,196 |
| Johnson & Johnson | 4 | $499 |
| GSK | 4 | $238 |
| Bristol Myers Squibb | 4 | $213 |
| Janssen Scientific Affairs, LLC | 2 | $152 |
| Legend Biotech USA Inc. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Merck | 1 | $18 |
| Autolus Inc | 1 | $17 |
| Bayer | 1 | $15 |
How this compares
$2,667,892 in reported general payments places this provider in the 90th percentile of 112 hematology & oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Portland
- Michael HeinrichPortland$25M
- Jay AndersenPortland$8.3M
- Elie TraerPortland$6.5M
- Jacqueline VukyPortland$5.4M
- Sandeep MashruPortland$4.6M
- Abdul Hai MansoorPortland$3.5M
- Aimee KohnPortland$3.3M
- Emerson ChenPortland$2.5M
- Brian DrukerPortland$2.5M
- Tony HoPortland$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.